Press Releases from Charles River
   
 
 
   
   
 

Charles River Announces Third-Quarter 2008 Results

Downloadable version.

  • Third-Quarter Sales Increase 9.0% to $342 Million
  • Third-Quarter GAAP EPS Increase 1.6% to $0.63 and Non-GAAP EPS Increase 10.1% to $.076
  • Company Updates 2008 Guidance

WILMINGTON, Mass.--(BUSINESS WIRE)--Nov. 5, 2008--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter and first nine months of 2008. For the quarter, net sales increased 9.0% to $342.2 million from $314.0 million in the third quarter of 2007. The Research Models and Services (RMS) segment reported very strong sales growth, partially offset by slower growth in the Preclinical Services (PCS) segment. Foreign exchange contributed 1.5% to the net sales growth.

Click here to read the full release.

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Jun 10 - Identifying Fungal Contamination i...
May 06 - Artifacts of Virus Filter Validati...
Jun 21-Jun 25 - Chicago, IL - American Diabetes Association’s 73rd Scientific Sessions
Sep 12-Sep 13 - Germantown. MD - Developing and Implementing Effective SOPs
Jun 18-Jun 18 - Basel, Switzerland - Seminar: Behavioral Biology in Mice and Rats

Charles River Laboratories, Inc.